Format

Send to

Choose Destination
Int Rev Immunol. 2006 Sep-Dec;25(5-6):353-75.

Heat shock protein vaccines: from bench to bedside.

Author information

1
Center for Immunotherapy of Cancer and Infectious Diseases, Department of Immunology, University of Connecticut School of Medicine, Farmington, Connecticut 06030-1920, USA. rbinder@up.uchc.edu

Abstract

Heat shock proteins (HSPs) are immunogenic, with the specificity of the immune response provided by the peptides that they chaperone. Binding of cell surface receptors by HSPs is central to the elicitation of the innate and adaptive immune responses obtained after vaccination and also plays a physiologic role in cross-priming. These effects of HSPs have been exploited in prophylaxis and therapy of cancer and infectious disease. The data obtained from murine studies have been translated into ongoing clinical trials of cancer of which the most recent results are provided here.

PMID:
17169780
DOI:
10.1080/08830180600992480
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center